Rehabilitation Management of Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy: Advances in Therapeutics

Volumn , Issue , 2006, Pages 149-176

  McDonald, Craig M ^a   Carter, Gregory T ^b   Han, Jay J ^b   Benditt, Joshua O ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77958012295     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780849374456-11     Document Type: Chapter

References (94)

1. Roberts RG, Coffey AJ, Bobrow M, Bentley DR. Exon structure of the human dystrophin gene. Genomics 1993; 16:536-540.
2. Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD. Characterization of dystrophin in muscle biopsies from Duchenne and Becker muscular dystrophy patients. N Engl J Med 1988; 318:1363-1368.
3. Emery AH. Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscul Disord 1991; 1:19-24.
4. McDonald CM, Abresch RT, Carter GT, et al. Profiles of neuromuscular diseases: Duchenne muscular dystrophy. Am J Phys Med Rehabil 1995; 74: S70-S92.
5. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 1989; 39:745-751.
6. Mendell JR, Province MA, Moxley RT, Griggs RC, Brooke MH. Clinical investigation of Duchenne muscular dystrophy: a methodology for therapeutic trials based on natural history controls. Arch Neurol 1987; 44:808-815.
7. Cros D, Harnden P, Pellisier JF, Serratrice G. Muscle hypertrophy in Duch-enne muscular dystrophy: a pathological and morphometric study. J Neurol 1989; 236:43-49.
8. Pradhan S. New clinical sign in Duchenne muscular dystrophy. Pediatr Neurol 1994; 11:298-301.
9. Kilmer DMD, Abresch RT, Fowler WM Jr. Serial manual muscle testing in Duchenne muscular dystrophy. Arch Phys Med Rehabil 1993; 74:1168-1174.
10. Steffensen BF, Lyager S, Werge B, Rahbek J, Mattson E. Physical capacity in nonambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol 2002; 44(9):623-632.
11. McDonald DG, Kinali M, Gallagher AC, et al. Fracture prevalence in Duch-enne muscular dystrophy. Dev Med Child Neurol 2002; 44(10):695-698.
12. Bakker JP, De Groot IJ, Beelen A, Lankhorst GJ. Predictive factors of cessation of ambulation in patients with Duchenne muscular dystrophy. Am J Phys Med Rehabil 2002; 81(12):906-912.
13. Johnson ER, Fowler WM Jr, Lieberman JS. Contractures in neuromuscular disease. Arch Phys Med Rehabil 1992; 73:807-814.
14. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA. Clinical investigation in Duchenne dystrophy II: determination of the ‘‘power’’ of therapeutic trials based on the natural history. Muscle Nerve 1983; 6:91-99.
15. Oda T, Shimizu N, Yonenobu K, Ono K, Nabeshima T, Kyoh S. Longitudinal study of spinal deformity in Duchenne muscular dystrophy. J Pediatr Orthop 1993; 13:478-486.
16. Scott OM, Hyde SA, Goddard C, Dubowitz V. Prevention of deformity in Duchenne muscular dystrophy: a prospective study of passive stretching and splintage. Physiotherapy 1981; 67:177-188.
17. Vignos PJ Jr, Archibald KC. Maintenance of ambulation in childhood muscular dystrophy. J Chron Dis 1960; 12:273-279.
18. Eyring EJ, Johnson EW, Burnett C. Surgery in muscular dystrophy. JAMA 1972; 222:1067-1071.
19. Siegel IM, Miller JE, Ray RD. Subcutaneous lower limb tenotomy in the treatment of pseudohypertrophic muscular dystrophy. J Bone Joint Surg 1986; 50-?A:1437-1444.
20. Spencer GE, Vignos PJ Jr. Bracing for ambulation in childhood progressive muscular dystrophy. J Bone Joint Surg 1962; 44-A:234-240.
21. Liu M, Mineo K, Hanayama K, Fujiwara T, Chino N. Practical problems and management of seating through the clinical stages of Duchenne muscular dystrophy. Arch Phys Med Rehabil 2003; 84(6):818-824.
22. Heckmatt JZ, Dubowitz V, Hyde SA, Florence J, Gabain AC, Thompson N. Prolongation of walking in Duchenne muscular dystrophy with lightweight orthoses: review of 57 cases. Dev Med Child Neurol 1985; 27:149-155.
23. McDonald C. Limb contractures in progressive neuromuscular disease and the role of stretching, orthotics, and surgery. Rehabil Neuro Disorders 1998; 9:187-194.
24. Vignos PJ Jr. Management of musculoskeletal complications in neuromuscular disease: limb contractures and the role of stretching, braces, and surgery. Phys Med Rehabil: State Art Rev 1988; 2:509-515.
25. Hart DA, McDonald CM. Spinal deformity in progressive neuromuscular disease: natural history and management. Phys Med Rehabil Clin N Am 1998; 9:213-220.
26. Manzur AY, Hyde SA, Rodillo E, Heckmatt JZ, Bentley G, Dubowitz V. A randomized controlled trial of early surgery in Duchenne muscular dystrophy. Neuromuscul Disord 1992; 2:379-386.
27. Johnson E, Yarnell S. Hand dominance and scoliosis in Duchenne muscular dystrophy. Arch Phys Med Rehabil 1976; 57:462-470.
28. Lord J, Behrman B, Varzos N, Cooper D, Lieberman JS, Fowler WM. Scoliosis associated with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1990; 71:13-19.
29. Rideau Y, Jankowski L, Grellet J. Respiratory function in the muscular dystrophies. Muscle Nerve 1981; 4:155-162.
30. Rideau Y, Glorion B, Delaubier A, Tarle O, Bach J. The treatment of scoliosis in Duchenne muscular dystrophy. Muscle Nerve 1984; 7:281-285.
31. Iannaccone ST, Owens H, Scott J, Teitell B. Postoperative malnutrition in Duchenne muscular dystrophy. J Child Neurol 2003; 18(1):17-20.
32. Braun NMT, Aurora NS, Rochester DF. Respiratory muscle and pulmonary function in poliomyositis and other proximal myopathies. Thorax 1983; 38:316-321.
33. Curran FJ. Night ventilation by body respirators for patients in chronic respiratory failure due to late stage Duchenne muscular dystrophy. Arch Phys Med Rehabil 1981; 62:270-275.
34. Bach JR. Pulmonary rehabilitation. In: The obstructive and paralytic conditions. Philadelphia: Hanley & Belfus, 1995:303-315.
35. Hahn A, Bach JR, Delaubier A, Renardel-Irani A, Guillou C, Rideau Y. Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1997; 78:1-12.
36. Splaingard ML, Frates RC Jr, Harrison GM, Carter RE, Jefferson LS. Home positive-pressure ventilation. Twentyyears’ experience. Chest 1983; 84(4):376-381.
37. Bach JR, Want TG. Noninvasive long-term ventilatory support for individuals with spinal muscular atrophy and functional bulbar musculature. Arch Phys Med Rehabil 1995; 76:213-217.
38. Bach JR, Campagnolo DI, Hoeman S. Life satisfaction of individuals with Duchenne muscular dystrophy using long-term mechanical ventilatory support. Am J Phys Med Rehabil 1991; 70:129-137.
39. Baydur A, Kanel G. Tracheobronchomalacia and tracheal hemorrhage in patients with Duchenne muscular dystrophy receiving long-term ventilation with uncuffed tracheostomies. Chest 2003; 123(4):1307-1311.
40. Gilgoff IS, Kahlstrom E, MacLaughlin E, Keens TG. Long-term ventilatory support in spinal muscular atrophy. J Pediatr 1989; 115:904-908.
41. Wang TG, Bach JR, Avila C, Alba AS, William Yang GF. Survival of individuals with spinal muscular atrophy on ventilatory support. Am J Phys Med Rehabil 1994; 73:207-215.
42. Topin N, Matecki S, Le Bris S, Rivier F, Echenne B, Prefaut C, Ramonatxo M. Dose-dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscul Disord 2002; 12(6):576-583.
43. Eagle M. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases Newcastle, January 2002. Neuromuscul Disord 2002; 12(10):975-983.
44. Benditt JO. Management of pulmonary complications in neuromuscular disease. Phys Med Rehabil Clin N Am 1998:167-185.
45. Yamamoto S, Matsushima H, Suzuki A. A comparative study of thallium-201 single photon emission computed tomography and electrocardiography in Duchenne and other types of muscular dystrophy. Am J Cardiol 1988; 61:836-641.
46. Mori H, Utsunomiya T, Ishijima M. The relationship between 24-hour total heart beats or ventricular arrhythmias and cardiopulmonary function in patients with Duchenne muscular dystrophy. Japan Heart J 1990; 31(5):599-610.
47. Yanagisawa A, Miyagawa M, Yotsukura M. The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy. Am Heart J 1992; 124:1244-1251.
48. Yotsukura M, Miyagawa M, Tsuya T. Pulmonary hypertension in progressive muscular dystrophy of the Duchenne type. Japan Circ J 1988; 52:321-326.
49. Nigro G, Comi LI, Politano L. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990; 26(3):277-284.
50. Nigro G, Comi LI, Politano L, Limongelli FM, Nigro V, DeRimini ML. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 1995; 18(3):283-289.
51. Akita H, Matsuoka S, Juroda Y. Predictive electrocardiographic score for evaluating prognosis in patients with Duchenne muscular dystrophy. Tokushima J Exp Med 1995; 40:55-61.
52. Miller G, D’Orsogna L, O’Shea JP. Autonomic function and the sinus tachycardia of Duchenne muscular dystrophy. Brain Dev 1989; 22:247-255.
53. Perloff JK. Cardiac rhythm and conduction in Duchenne muscular dystrophy. J Am Coll Cardiol 1984; 3:1263-1270.
54. Sanyal SK, Johnson WW, Thapar MK. An ultrastructural basis for the electrocardiographic alteration associated with Duchenne progressive muscular dystrophy. Circulation 1978; 57:1122-1130.
55. Takenaka A, Yokota M, Iwase M. Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophy. Eur Heart J 1993; 14(5):669-675.
56. Chenard AA, Becane HM, Tertrain F, Weiss YA. Systolic time intervals in Duchenne muscular dystrophy: evaluation of left ventricular performance. Clin Cardiol 1998; 11:407-411.
57. Nagai T. Prognostic evaluation of congestive heart failure in patients with Duchenne muscular dystrophy: a retrospective study using non-invasive cardiac function tests. Japan Circ J 1989; 53(5):406-412.
58. Gilroy J, Cahalan J, Berman R. Cardiac and pulmonary complications in Duchenne progressive muscular dystrophy. Circulation 1963; 27:484-488.
59. Leth A, Wulff K. Myocardiopathy in Duchenne progressive muscular dystrophy. Acta Paediatr Scand 1976; 65:28-35.
60. Lewis W, Yadlapalli S. Management of cardiac complications in neuromuscular disease. Phys Med Rehabil Clin N Am 1998; 9:145-156.
61. Rappaport D, Colleto GM, Vainzof M, Duaik MC, Zatz M. Short stature in Duchenne muscular dystrophy. Growth Regulation 1991; 1:11-21.
62. Eiholzer U, Boltshauser E, Frey D, Molinari L, Zachmann U. Short stature: a common feature in Duchenne muscular dystrophy. Eur J Pediatr 1988; 147:602-610.
63. Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 1982; 5:291-301.
64. Willig TN, Carlier L, Legrand M, Riviere H, Navarro J. Nutritional assessment in Duchenne muscular dystrophy. Dev Med Child Neurol 1993; 35:1074-1081.
65. Okada K, Manabe S, Sakamoto S, Ohnaka M, Niiyama Y. Protein and energy metabolism in patients with progressive muscular dystrophy. J Nutr Sci Vitami-nol (Tokyo) 1992; 38:141-155.
66. Okada K, Manabe S, Sakamoto S, Ohnaka M, Niiyama Y. Predictions of energy intake and energy allowance of patients with Duchenne muscular dystrophy and their validity. J Nutr Sci Vitaminol (Tokyo) 1992; 38:155-161.
67. Jaffe KM, McDonald CM, Ingman E, Haas J. Symptoms of upper gastrointestinal dysfunction: case-control study. Arch Phys Med Rehabil 1990; 71:742-751.
68. Edwards RHT, Round JM, Jackson MJ. Weight reduction in boys with muscular dystrophy. Dev Med Child Neurol 1984; 26:384-390.
69. Goldstein M, Meyer S, Freund HR. Effects of overfeeding children with muscle dystrophies. J Parent Enteral Nutr 1989; 13:603-610.
70. McCrory M, Wright N, Kilmer D. Nutritional aspects of neuromuscular diseases. Phys Med Rehabil Clin N Am 1998; 9:127-136.
71. Stewart PM, Walser M, Drachman DB. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy. Muscle Nerve 1982; 5:197-215.
72. Benson ES, Jaffe KM, Tarr PI. Acute gastric dilatation in Duchenne muscular dystrophy: a case report and review of the literature. Arch Phys Med Rehabil 1996; 77:512-517.
73. Nudel L, Zuk D, Zeelan E. DMD gene product is not identical in muscle and brain. Nature 1989; 337:76-78.
74. Dorman C, Hurley AD, D’Avignon J. Language and learning disorders of older boys with Duchenne muscular dystrophy. Dev Med Child Neurol 1988; 30: 316-321.
75. Marsh GG, Munsat TL. Evidence of early impairment of verbal intelligence in Duchenne muscular dystrophy. Arch Dis Child 1974; 49:118-125.
76. Sollee ND, Latham EE, Kinndlon DJ, Bresnan MJ. Neuropsychological impairment in Duchenne muscular dystrophy. J Clin Exp Neuropsychol 1985; 7:486-491.
77. Carter GT, Kikuchi N, Abresch RT, Walsh SA, Horasek S, Fowler WM. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehabil 1994; 75(5):555-559.
78. Carter GT, Wineinger MA, Walsh SA, Horasek SJ, Abresch RT, Fowler WM. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neu-romuscul Disord 1995; 5(4):323-331.
79. Edwards RHT, Newham DJ, Jones DA, Chapman SJ. Role of mechanical damage in pathogenesis of proximal myopathy in man. Lancet 1984; 8376:548-555.
80. Bonsett CA. Pseudohypertrophic muscular dystrophy: distribution of degenerative features as revealed by anatomical study. Neurology 1963; 13:728-733.
81. Johnson EW, Braddom R. Over-work weakness in facioscapulohumeral muscular dystrophy. Arch Phys Med Rehabil 1971; 52:333-338.
82. Kilmer DD, Abresch RT, McCrory MA, et al. Profiles of neuromuscular diseases: facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil 1995; 74:S131-S139.
83. Vignos PJ Jr, Watkins MP. Effect of exercise in muscular dystrophy. JAMA 1966; 197:843-850.
84. Scott OM, Hyde SA, Goddard C. Effect of exercise in Duchenne muscular dystrophy: controlled six-month feasibility study of effects of two different regimes of exercises in children with Duchenne dystrophy. Physiotherapy 1981; 67:174-180.
85. DeLateur BJ, Giaconi RM. Effect on maximal strength of submaximal exercise in Duchenne muscular dystrophy. Am J Phys Med 1979; 58:26-33.
86. Carter GT, Abresch RT, Fowler WM. Adaptations to exercise training and contraction-induced muscle injury in animal models of neuromuscular disease. Am J Phys Med Rehabil 2002; 81:S151-S161.
87. Vignos PJ Jr. Physical models of rehabilitation in neuromuscular disease. Muscle Nerve 1983; 6:323-325.
88. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1993; 74:711-719.
89. Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1994; 75:560-565.
90. Sockolov R, Irwin B, Dressendorfer RH, Fowler WM. Exercise performance in 6 to 11 year old boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1977; 58:195-201.
91. Wright NC, Kilmer DD, McCrory MA, Aitkens SG, Holcomb BJ, Bernauer EM. Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil 1996; 77:64-70.
92. Butler C, Okamoto G, McKay T. Motorized wheelchair driving by disabled children. Arch Phys Med Rehabil 1984; 65:95-101.
93. Butler C, Okamoto G, McKay T. Powered mobility for very young disabled children. Dev Med Child Neurol 1983; 25:472-476.
94. Eagle M, Badouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvement in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002; 12(10):926-929.